Nu Skin Enterprises, Inc.

Historical 13F Holders

Symbol
NUS
CUSIP
67018T105
All holders as of
Q2 2026
Type
Equity
Class
CL A
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 67018T105 since 12/18/2024, newest first.

Filer % of Class Filed
Charles Schwab Investment Management Inc 13G/A Amendment 1 4.5% 5/14/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 17 0% 3/27/2026
Event 3/13/2026
Charles Schwab Investment Management Inc 13G 5.4% 2/12/2026
Event 12/31/2025
BlackRock, Inc. 13G/A Amendment 12 7.6% 4/17/2025
Event 3/31/2025
Vanguard Group Inc 13G/A Amendment 16 7.9% 1/31/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 12 163 k $966 k
2026 Q2 167 36.2 M $203 M
2026 Q1 180 36.3 M $265 M
2025 Q4 193 37.0 M $356 M
2025 Q3 201 36.7 M $448 M
2025 Q2 186 38.3 M $306 M
2025 Q1 201 36.3 M $264 M
2024 Q4 206 37.8 M $260 M
2024 Q3 208 38.9 M $287 M
2024 Q2 214 43.4 M $458 M
2024 Q1 212 42.1 M $583 M
2023 Q4 229 42.3 M $821 M
2023 Q3 222 41.0 M $871 M
2023 Q2 226 43.1 M $1.43 B
2023 Q1 219 44.9 M $1.77 B
2022 Q4 233 52.2 M $2.20 B
2022 Q3 220 44.2 M $1.48 B
2022 Q2 232 44.2 M $1.91 B
2022 Q1 250 43.6 M $2.08 B
2021 Q4 277 42.5 M $2.16 B
2021 Q3 263 40.1 M $1.62 B
2021 Q2 295 41.5 M $2.35 B
2021 Q1 294 39.8 M $2.11 B
2020 Q4 285 40.7 M $2.22 B
2020 Q3 267 38.8 M $1.94 B
2020 Q2 249 39.3 M $1.50 B
2020 Q1 220 39.1 M $852 M
2019 Q4 243 42.0 M $1.72 B
2019 Q3 254 41.2 M $1.75 B
2019 Q2 291 42.1 M $2.07 B
2019 Q1 309 44.0 M $2.10 B
2018 Q4 296 43.6 M $2.67 B
2018 Q3 330 44.3 M $3.64 B
2018 Q2 319 43.6 M $3.40 B
2018 Q1 316 43.3 M $3.18 B
2017 Q4 298 40.8 M $2.77 B
2017 Q3 282 41.7 M $2.57 B
2017 Q2 294 42.9 M $2.69 B
2017 Q1 289 46.4 M $2.58 B
2016 Q4 280 40.7 M $1.95 B
2016 Q3 267 42.1 M $2.72 B
2016 Q2 230 43.8 M $2.02 B
2016 Q1 225 45.9 M $1.77 B
2015 Q4 238 48.5 M $1.84 B
2015 Q3 238 45.7 M $1.89 B
2015 Q2 230 44.6 M $2.10 B
2015 Q1 232 45.1 M $2.71 B
2014 Q4 249 46.5 M $2.04 B
2014 Q3 262 45.2 M $2.05 B
2014 Q2 310 40.8 M $3.02 B
2014 Q1 330 41.8 M $3.46 B